Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,460 | -9,130 | -4,600 | -16,360 | -12,070 |
| Depreciation Amortization | 2,060 | 1,360 | 660 | 2,010 | 1,530 |
| Other Working Capital | -2,410 | -2,130 | -2,890 | 2,670 | -580 |
| Other Operating Activity | -30 | -50 | -30 | -10 | 10 |
| Operating Cash Flow | $-13,840 | $-9,950 | $-6,860 | $-11,690 | $-11,110 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,960 | -2,170 | -1,150 | -4,580 | -4,220 |
| Other Investing Activity | 11,370 | 7,370 | 3,300 | 9,040 | 1,970 |
| Investing Cash Flow | $7,410 | $5,200 | $2,150 | $4,460 | $-2,250 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,250 | 500 | -430 | 5,570 | 710 |
| Financing Cash Flow | $1,250 | $500 | $-430 | $5,570 | $710 |
| Beginning Cash Position | 21,550 | 21,550 | 21,550 | 23,200 | 23,200 |
| End Cash Position | 16,360 | 17,300 | 16,400 | 21,550 | 10,550 |
| Net Cash Flow | $-5,180 | $-4,250 | $-5,140 | $-1,640 | $-12,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,840 | -9,950 | -6,860 | -11,690 | -11,110 |
| Free Cash Flow | -13,840 | -9,950 | -6,860 | -11,690 | -11,110 |